NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- RUMI Scientific, Inc. (“RUMI”) a developer of therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening...
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (Rumi€), a developer of therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening...
Rumi Scientific Announces Data Demonstrating Disease Modifying Effect of BRD9 Inhibition in a Huntington’s Disease Animal Model